You are here:

Archived: Emtricitabine 200mg hard capsules (Emtriva®)


Following a full submission.

Emtricitabine (Emtriva) is not recommended for use within NHS Scotland for the treatment of HIV-1 infected adults and children. In combination with other antiretroviral agents it produces a viral response in treatment-naïve patients and those previously stabilised on other antiretrovirals. However, an economic evaluation was not provided, thus the economic case is not demonstrated.

Drug Details

Drug Name: Emtricitabine 200mg hard capsules (Emtriva®)
SMC Drug ID: 105/04
Manufacturer: Gilead Sciences Ltd
Indication: HIV-1 infected adults in combination with other antiretroviral agents
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 12 July 2004

Current Advice

Resubmission 13 February 2006